CANBRIDGE PHARMACEUTICALS INC. (01228)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Chan Peng Kuan | 11-Jun-21 | INED | |||
| Chen Kan | 16-Dec-20 | 02-Sep-24 | NED | ||
| Di Rocco Derek Paul | 10-Mar-20 | 23-Nov-23 | NED | ||
| Geraghty James Arthur | 18-Jul-18 | INED | |||
| Gregory Richard James | 21-Apr-20 | INED | |||
| Hu Edward | 05-Jul-22 | 30-Sep-24 | NED | ||
| Hu Lan | 16-Feb-22 | INED | |||
| Le Xiao | 16-Dec-20 | 05-Jul-22 | NED | ||
| Li Fangxin | 30-Sep-24 | NED | |||
| Ma Qian | 21-Jun-21 | CoSec | |||
| Qian Ma | 30-Mar-26 | AuRep | |||
| Wong Keith Shing Cheung | 21-Jun-21 | 01-Apr-22 | CoSec | ||
| Wong Wai Chiu | 01-Apr-22 | J-CoSec, CoSec | |||
| Xue James Qun | 30-Jan-18 | Ch, CEO, Fdr | |||
| Zhao Wei | 30-Jun-25 | MbCC |